Julie Deguil

512 total citations
23 papers, 391 citations indexed

About

Julie Deguil is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Julie Deguil has authored 23 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cellular and Molecular Neuroscience, 7 papers in Molecular Biology and 7 papers in Cognitive Neuroscience. Recurrent topics in Julie Deguil's work include Neuroscience and Neuropharmacology Research (6 papers), Memory and Neural Mechanisms (6 papers) and Alzheimer's disease research and treatments (2 papers). Julie Deguil is often cited by papers focused on Neuroscience and Neuropharmacology Research (6 papers), Memory and Neural Mechanisms (6 papers) and Alzheimer's disease research and treatments (2 papers). Julie Deguil collaborates with scholars based in France, Italy and Switzerland. Julie Deguil's co-authors include Bernard Fauconneau, Stéphanie Pain, Claire Lafay‐Chebassier, François Chavant, Régis Bordet, Marie Christine Pérault‐Pochat, Sébastien Dupont, Laurent Beney, Gilles Frapper and Adrià Gil and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, British Journal of Pharmacology and Journal of Cerebral Blood Flow & Metabolism.

In The Last Decade

Julie Deguil

22 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie Deguil France 9 145 131 90 57 50 23 391
Thomas Lorivel France 14 128 0.9× 142 1.1× 118 1.3× 89 1.6× 62 1.2× 19 412
Chrysoula Dioli Portugal 9 160 1.1× 95 0.7× 156 1.7× 57 1.0× 54 1.1× 14 401
Nicole L. Bjorklund United States 12 144 1.0× 159 1.2× 152 1.7× 63 1.1× 26 0.5× 15 399
Jing Xiong China 14 125 0.9× 127 1.0× 61 0.7× 54 0.9× 19 0.4× 21 486
Keisuke Tamaki Japan 9 184 1.3× 163 1.2× 69 0.8× 35 0.6× 26 0.5× 11 398
Emily F. Collier United States 5 179 1.2× 177 1.4× 147 1.6× 75 1.3× 38 0.8× 7 534
Carine Gandin France 7 181 1.2× 124 0.9× 109 1.2× 63 1.1× 29 0.6× 7 416
Erik G. Gentry United States 6 163 1.1× 170 1.3× 246 2.7× 76 1.3× 28 0.6× 7 439
Liubov S. Kalinichenko Germany 15 183 1.3× 92 0.7× 114 1.3× 67 1.2× 36 0.7× 50 489
Gorka Gereñu Spain 14 160 1.1× 144 1.1× 217 2.4× 71 1.2× 25 0.5× 19 508

Countries citing papers authored by Julie Deguil

Since Specialization
Citations

This map shows the geographic impact of Julie Deguil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Deguil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Deguil more than expected).

Fields of papers citing papers by Julie Deguil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Deguil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Deguil. The network helps show where Julie Deguil may publish in the future.

Co-authorship network of co-authors of Julie Deguil

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Deguil. A scholar is included among the top collaborators of Julie Deguil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Deguil. Julie Deguil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carton, Louise, F. Auger, Nicolas Durieux, et al.. (2024). Does concomitant diazepam and ethanol use modulate age-related cognitive decline in mice?. Life Sciences. 359. 123216–123216.
2.
Carton, Louise, Maéva Kyheng, Maud Pétrault, et al.. (2021). Lack of direct involvement of a diazepam long-term treatment in the occurrence of irreversible cognitive impairment: a pre-clinical approach. Translational Psychiatry. 11(1). 612–612. 7 indexed citations
3.
Deguil, Julie & Régis Bordet. (2021). Contributions of animal models of cognitive disorders to neuropsychopharmacology. Therapies. 76(2). 87–99. 2 indexed citations
4.
Colin, Olivier, Julien Labreuche, Julie Deguil, et al.. (2019). Preadmission use of benzodiazepines and stroke outcomes: the Biostroke prospective cohort study. BMJ Open. 9(1). e022720–e022720. 8 indexed citations
5.
Pain, Stéphanie, et al.. (2019). Regulation of Protein Synthesis and Apoptosis in Lymphocytes of Parkinson Patients: The Effect of Dopaminergic Treatment. Neurodegenerative Diseases. 19(5-6). 178–183. 3 indexed citations
6.
Deguil, Julie, Laura Ravasi, Yves Lamberty, et al.. (2016). Early Development of Symptomatic Drugs in AD: A Systematic Review of the Use of Biomarkers. CNS & Neurological Disorders - Drug Targets. 15(7). 823–836. 6 indexed citations
7.
Cassé‐Perrot, Catherine, Laura Lanteaume, Julie Deguil, et al.. (2016). Neurobehavioral and Cognitive Changes Induced by Sleep Deprivation in Healthy Volunteers. CNS & Neurological Disorders - Drug Targets. 15(7). 777–801. 17 indexed citations
8.
Lanteaume, Laura, Catherine Cassé‐Perrot, Marie‐Noëlle Lefebvre, et al.. (2016). Neurobehavioral and Cognitive Changes Induced by Hypoxia in Healthy Volunteers. CNS & Neurological Disorders - Drug Targets. 15(7). 816–822. 4 indexed citations
9.
Deguil, Julie, Laura Ravasi, Laura Lanteaume, Yves Lamberty, & Régis Bordet. (2016). Translational Challenge Models in Support of Efficacy Studies: Effect of Cerebral Hypoxia on Cognitive Performances in Rodents. CNS & Neurological Disorders - Drug Targets. 15(7). 765–776. 5 indexed citations
10.
Boucart, Muriel, George A. Michael, Nawal Waucquier, et al.. (2015). Cholinergic modulation of stimulus-driven attentional capture. Behavioural Brain Research. 283. 47–52. 5 indexed citations
11.
Boucart, Muriel, Giovanna Bubbico, Sébastien Szaffarczyk, et al.. (2015). Donepezil increases contrast sensitivity for the detection of objects in scenes. Behavioural Brain Research. 292. 443–447. 19 indexed citations
12.
Deguil, Julie, Alexandra Auffret, Claudio Babiloni, et al.. (2013). Evaluation of symptomatic drug effects in Alzheimer's disease: strategies for prediction of efficacy in humans. Drug Discovery Today Technologies. 10(3). e329–e342. 6 indexed citations
13.
Rolland, Benjamin, Julie Deguil, Renaud Jardri, et al.. (2013). Therapeutic Prospects of PPARs in Psychiatric Disorders: A Comprehensive Review. Current Drug Targets. 14(7). 724–732. 27 indexed citations
14.
Deguil, Julie, Sébastien Dupont, Laurent Beney, et al.. (2010). Modulation of Lipid‐Induced ER Stress by Fatty Acid Shape. Traffic. 12(3). 349–362. 72 indexed citations
15.
Deguil, Julie, et al.. (2010). Time course of MPTP toxicity on translational control protein expression in mice brain. Toxicology Letters. 196(1). 51–55. 2 indexed citations
16.
Chavant, François, Julie Deguil, Stéphanie Pain, et al.. (2009). Imipramine, in Part through Tumor Necrosis Factor α Inhibition, Prevents Cognitive Decline and β-Amyloid Accumulation in a Mouse Model of Alzheimer's Disease. Journal of Pharmacology and Experimental Therapeutics. 332(2). 505–514. 64 indexed citations
17.
Deguil, Julie, et al.. (2009). Neuroprotective Effect of PACAP on Translational Control Alteration and Cognitive Decline in MPTP Parkinsonian Mice. Neurotoxicity Research. 17(2). 142–155. 62 indexed citations
18.
Deguil, Julie, Marie Christine Pérault‐Pochat, François Chavant, et al.. (2008). Activation of the protein p7OS6K via ERK phosphorylation by cholinergic muscarinic receptors stimulation in human neuroblastoma cells and in mice brain. Toxicology Letters. 182(1-3). 91–96. 16 indexed citations
19.
Deguil, Julie, Guylène Page, Bernard Fauconneau, et al.. (2007). Neuroprotective effects of pituitary adenylate cyclase–activating polypeptide (PACAP) in MPP+‐induced alteration of translational control in Neuro‐2a neuroblastoma cells. Journal of Neuroscience Research. 85(9). 2017–2025. 35 indexed citations
20.
Pain, Stéphanie, Laurence Barrier, Julie Deguil, et al.. (2007). A cell-permeable peptide inhibitor TAT-JBD reduces the MPP+-induced caspase-9 activation but does not prevent the dopaminergic degeneration in substantia nigra of rats. Toxicology. 243(1-2). 124–137. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Lorivel Breakdown of academic impact, for papers by Chrysoula Dioli Breakdown of academic impact, for papers by Nicole L. Bjorklund Breakdown of academic impact, for papers by Jing Xiong Breakdown of academic impact, for papers by Keisuke Tamaki Breakdown of academic impact, for papers by Emily F. Collier Breakdown of academic impact, for papers by Carine Gandin Breakdown of academic impact, for papers by Erik G. Gentry Breakdown of academic impact, for papers by Liubov S. Kalinichenko Breakdown of academic impact, for papers by Gorka Gereñu
Rankless by CCL
2026